The direct antiglobulin test in a hospital setting

J Cid1, X Ortín, V Beltran

  • 1Centre de Transfusió i Banc de Teixits, Tarragona. C/. Dr. Mallafré Guasch, 4, 43007 Tarragona, Spain.

Immunohematology
|September 18, 2004
PubMed

Insights

The Direct Antiglobulin Test (DAT) is rarely positive in suspected hemolytic anemia cases. A comprehensive laboratory evaluation for hemolytic anemia should precede DAT testing for better diagnostic accuracy.

Area of Science:

  • Clinical Pathology
  • Hematology
  • Immunology

Background:

  • The Direct Antiglobulin Test (DAT) is a crucial diagnostic tool for suspected hemolytic anemia.
  • Understanding the utility and appropriate utilization of DAT in clinical practice is essential.

Purpose of the Study:

  • To assess the current application and diagnostic yield of the DAT in a hospital setting.
  • To determine the correlation between DAT results and comprehensive laboratory evaluations for hemolytic anemia.

Main Methods:

  • Retrospective chart review of 463 patients who underwent DAT testing between April 1999 and October 2001.
  • Collected data included DAT results and findings from prior laboratory evaluations for hemolytic anemia.
  • Analysis of DAT positivity rates based on the number of clinical signs of hemolysis.

Main Results:

  • The DAT was negative in 93.7% (434/463) and positive in 6.3% (29/463) of cases.
  • A complete laboratory evaluation for hemolytic anemia was performed in 38.7% (179/463) of patients.
  • A higher incidence of positive DAT was observed in patients with more than two signs of hemolysis (11.8%) compared to those with two or fewer signs (3.4%).

Conclusions:

  • The DAT demonstrates a low positivity rate in the evaluated patient population.
  • A comprehensive laboratory workup for suspected hemolytic anemia should be prioritized before ordering a DAT.
  • This approach may improve diagnostic efficiency and resource utilization in investigating anemia.